Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B - PubMed (original) (raw)
. 1995 May 15;85(10):2918-28.
Affiliations
- PMID: 7742552
Free article
Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B
H M Chen et al. Blood. 1995.
Free article
Abstract
PU.1 (the Spi-1 oncogene) and Spi-B are closely related members of the ets transcription factor family, sharing similar DNA binding specificities mediated by similar DNA binding domains. PU.1 and Spi-B have been previously described as being predominantly expressed coordinately in macrophages and B cells, but their expression in early hematopoietic stages and during the course of myeloid differentiation to monocytes and macrophages or to neutrophils has not been extensively investigated. Here, we report that PU.1 mRNA is upregulated during myeloid differentiation of human purified CD34+ cells and murine multipotential FDCP-mix A4 cells, suggesting that PU.1 is upregulated as an early event during differentiation of multipotential progenitor cells. PU.1 expression is maintained at stable levels during differentiation of myeloid cell lines U937 and HL-60 to monocytic and neutrophilic cells. PU.1 is expressed at highest levels in mature human monocytes and human peripheral blood neutrophils. In contrast to PU.1, significant levels of Spi-B mRNA and protein are found only in some B-cell lines and spleen but are not found in myeloid cell lines, neutrophils, or macrophages. In vitro translated Spi-B protein can bind to PU.1 binding sites in myeloid promoters and transactivate these promoters in nonmyeloid cells. Therefore, although PU.1 and Spi-B may bind to similar DNA control elements and have redundancy of transactivation function in vitro, the lack of significant levels of Spi-B in myeloid cells makes it unlikely that Spi-B plays a significant role in myeloid lineage development and gene expression. In contrast, PU.1 is expressed at high levels not only in monocytes and macrophages but also in neutrophils, indicating that PU.1 can activate gene expression in both major myeloid lineages.
Similar articles
- PU.1 (Spi-1) autoregulates its expression in myeloid cells.
Chen H, Ray-Gallet D, Zhang P, Hetherington CJ, Gonzalez DA, Zhang DE, Moreau-Gachelin F, Tenen DG. Chen H, et al. Oncogene. 1995 Oct 19;11(8):1549-60. Oncogene. 1995. PMID: 7478579 - The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
Su GH, Ip HS, Cobb BS, Lu MM, Chen HM, Simon MC. Su GH, et al. J Exp Med. 1996 Jul 1;184(1):203-14. doi: 10.1084/jem.184.1.203. J Exp Med. 1996. PMID: 8691135 Free PMC article. - PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene.
Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang DE, Tenen DG. Hohaus S, et al. Mol Cell Biol. 1995 Oct;15(10):5830-45. doi: 10.1128/MCB.15.10.5830. Mol Cell Biol. 1995. PMID: 7565736 Free PMC article. - Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters.
Zhang DE, Hohaus S, Voso MT, Chen HM, Smith LT, Hetherington CJ, Tenen DG. Zhang DE, et al. Curr Top Microbiol Immunol. 1996;211:137-47. doi: 10.1007/978-3-642-85232-9_14. Curr Top Microbiol Immunol. 1996. PMID: 8585944 Review. - Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
Gangenahalli GU, Gupta P, Saluja D, Verma YK, Kishore V, Chandra R, Sharma RK, Ravindranath T. Gangenahalli GU, et al. Stem Cells Dev. 2005 Apr;14(2):140-52. doi: 10.1089/scd.2005.14.140. Stem Cells Dev. 2005. PMID: 15910240 Review.
Cited by
- Inferring gene regulatory network from single-cell transcriptomes with graph autoencoder model.
Wang J, Chen Y, Zou Q. Wang J, et al. PLoS Genet. 2023 Sep 13;19(9):e1010942. doi: 10.1371/journal.pgen.1010942. eCollection 2023 Sep. PLoS Genet. 2023. PMID: 37703293 Free PMC article. - The Entry and Egress of Monocytes in Atherosclerosis: A Biochemical and Biomechanical Driven Process.
Kang H, Li X, Xiong K, Song Z, Tian J, Wen Y, Sun A, Deng X. Kang H, et al. Cardiovasc Ther. 2021 Jul 8;2021:6642927. doi: 10.1155/2021/6642927. eCollection 2021. Cardiovasc Ther. 2021. PMID: 34345249 Free PMC article. Review. - Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML.
Trinh BQ, Ummarino S, Zhang Y, Ebralidze AK, Bassal MA, Nguyen TM, Heller G, Coffey R, Tenen DE, van der Kouwe E, Fabiani E, Gurnari C, Wu CS, Angarica VE, Yang H, Chen S, Zhang H, Thurm AR, Marchi F, Levantini E, Staber PB, Zhang P, Voso MT, Pandolfi PP, Kobayashi SS, Chai L, Di Ruscio A, Tenen DG. Trinh BQ, et al. Blood. 2021 Oct 14;138(15):1331-1344. doi: 10.1182/blood.2020007920. Blood. 2021. PMID: 33971010 Free PMC article. - Regulation of Expression and Latency in BLV and HTLV.
Pluta A, Jaworski JP, Douville RN. Pluta A, et al. Viruses. 2020 Sep 25;12(10):1079. doi: 10.3390/v12101079. Viruses. 2020. PMID: 32992917 Free PMC article. Review. - High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
Kim S, Bagadia P, Anderson DA 3rd, Liu TT, Huang X, Theisen DJ, O'Connor KW, Ohara RA, Iwata A, Murphy TL, Murphy KM. Kim S, et al. Immunity. 2020 Oct 13;53(4):759-774.e9. doi: 10.1016/j.immuni.2020.07.018. Epub 2020 Aug 13. Immunity. 2020. PMID: 32795402 Free PMC article.